See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2018_Celldex_Therapeutics_Inc.pdf
Logs
info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 51,519,000 |
1 | LiabilitiesCurrent | 27,736,000 |
2 | remainder_Liabilities | 0 |
3 | AssetsCurrent | 144,756,000 |
4 | AssetsNoncurrent | 1,929,000 |
5 | PropertyPlantAndEquipmentNet | 10,372,000 |
6 | Goodwill | 158,567,000 |
7 | remainder_Assets | 0 |
8 | GeneralAndAdministrativeExpense | 25,003,000 |
9 | ResearchAndDevelopmentExpense | 96,171,000 |
10 | remainder_Expenses | -11,186,000 |
11 | remainder_Revenues | 16,957,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 23,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 79,255,000 |
1 | Assets | 315,624,000 |
2 | Expenses | 109,988,000 |
3 | Revenues | 16,957,000 |
4 | StockholdersEquity | 236,369,000 |
5 | NetIncome | -93,031,000 |
6 | ComprehensiveNetIncome | -93,019,500 |
7 | BaseVar | 260,923,500 |
8 | EconomicCapitalRatio | 0.546 |